Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Deficiency, Mental

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Deficiency, Mental in 2 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rosenberger, G1
Meien, S1
Kutsche, K1
Jacoby, M1
Cox, JJ1
Gayral, S1
Hampshire, DJ1
Ayub, M1
Blockmans, M1
Pernot, E1
Kisseleva, MV1
Compère, P1
Schiffmann, SN1
Gergely, F1
Riley, JH1
Pérez-Morga, D1
Woods, CG1
Schurmans, S1

Other Studies

2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Deficiency, Mental

ArticleYear
Oncogenic HRAS mutations cause prolonged PI3K signaling in response to epidermal growth factor in fibroblasts of patients with Costello syndrome.
    Human mutation, 2009, Volume: 30, Issue:3

    Topics: Abnormalities, Multiple; Cells, Cultured; Chromones; Craniofacial Abnormalities; Enzyme Inhibitors;

2009
INPP5E mutations cause primary cilium signaling defects, ciliary instability and ciliopathies in human and mouse.
    Nature genetics, 2009, Volume: 41, Issue:9

    Topics: Animals; Bardet-Biedl Syndrome; Cell Line; Cell Nucleus; Cells, Cultured; Chromones; Cilia; Culture

2009